CVS/pharmacy announced on Thursday the launch of a new online Drug Information Center on CVS.com, which was developed to help consumers take control of their health by providing them with drug information and a variety of innovative resources.
The Consumer Healthcare Products Association endorsed the Restoring Access to Medication Act (H.R. 2835), which would repeal a requirement enacted into law as part of the Patient Protection and Affordable Care Act of 2010 that requires consumers to obtain a prescription in order to utilize their flexible spending arrangements and health savings accounts to purchase over-the-counter medicines.
An op-ed in Tuesday’s Capitol Hill newspaper Roll Call emphasizes the National Association of Chain Drug Stores’ commitment to curbing prescription drug abuse and diversion while ensuring legitimate patient access to prescription medications.
According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older.
The creation of a clear approval pathway for biosimilar drugs remains a daunting task for the Food and Drug Administration, despite the fact that it's prescribed by law through the Patient Protection and Affordable Care Act. But when those lower-priced, generic versions of some staggeringly expensive bioengineered medicines do finally come to market, they're likely to have a profound effect on the nation's outlays for specialty pharmaceuticals.
Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.
CVS/pharmacy has bolstered its mobile app by adding the new Drug Interaction Checker, which is an industry first that allows customers to easily check for potential drug interactions by comparing OTC products with their prescriptions and other OTCs on their smartphones.
The healthcare industry continues to prepare for ACA implementation and the expected influx of newly eligible patients, said Emdeon's Kevin Mahoney. Many pharmacies are changing their staffing models in preparation for customers with expanded Medicaid benefits — especially as we approach the New Year. This is a good time for me to remind you to be thinking about your eligibility program.
Retail pharmacists will be missing out on as much as a $20 billion opportunity if they don't identify how to consistently and efficiently engage their patients, suggested Jeff Rehling, principal at Edgewood Consulting Group, during a business session Sunday at the recent 2013 GMDC Health & Wellness @ Retail Conference.
When does the double-edged sword of generic drug price reductions begin to cut the government agency or health system holding the sword?
That's the question many pharmacy leaders in Canada have for the provincial health system policy-makers who have embarked on a crusade to whack pharmacy reimbursement levels for many lower-cost generic medicines sold under the nation's publicly funded health system.
Over-the-counter health-and-wellness items play a key role in bridging a supermarket retail pharmacy to the rest of the food store. And with extensive outcomesbased medicines on the horizon, more health-seeking consumers will look to make that link between pharmacy and nutrition.
Finals can be a stressful time for any college or graduate student, with many hours spent studying and few spent socializing or relaxing. But many students are using prescription drugs to get through finals, according to a new study.
A Walgreens survey found that 37% of Medicare Part D beneficiaries have daily concerns about their prescription drug costs, and 1-in-5 say they’ve had to make sacrifices, such as delaying filling a prescription or skipping doses, to help manage medication costs.
The Food and Drug Administration may soon find itself in another Plan-B-generated quandary — the complications around granting a three-year marketing exclusivity for a medicine that is both prescription-only and over-the-counter, according to an FDA Law Blog posted Sunday by Hyman, Phelps & McNamara.